Wednesday, November 11, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 24, 2026

EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance

View original at finance.yahoo.com
EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance EXL 2025Fourth Quarter Revenue of $542.6 Million, up12.7% year-over-year Q4 Diluted EPS (GAAP) of $0.38, up21.8% from $0.31 in Q4 of 2024 Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $0.50, up15.0% from $0.44 in Q4 of 2024 2025 Revenue of $2.09 Bil…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2026 adjusted diluted EPS expected to be $2.14 to $2.19, representing 10% to 12% increase over 2025

    80% confidence

  • Delivered revenue growth of 12.7% and increased adjusted diluted EPS by 15.0% year-over-year in Q4 2025

    80% confidence

  • The $500 million stock repurchase authorization represents confidence in ability to continue growth trajectory and generate significant free cash flow

    80% confidence

  • 2026 revenue expected to be $2.275 billion to $2.315 billion, reflecting 9% to 11% year-over-year growth

    80% confidence

  • EXL's sustained double-digit growth demonstrates the strength of competitive position as a global data and AI company

    80% confidence

  • Investments in building innovative data and AI services and solutions, growing partner ecosystem, and cultivating AI-native talent are driving growth momentum

    80% confidence

  • Closed 2025 with robust growth across business segments, a formidable balance sheet and strong free cash flow

    80% confidence

  • EXL's recognized industry expertise and leadership in embedding AI in clients' businesses are resonating strongly with the market and fueling growth

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance — Source | Via News | Via News